These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 29102279

  • 1. Microdosimetric Evaluation of Current and Alternative Brachytherapy Sources-A Geant4-DNA Simulation Study.
    Famulari G, Pater P, Enger SA.
    Int J Radiat Oncol Biol Phys; 2018 Jan 01; 100(1):270-277. PubMed ID: 29102279
    [Abstract] [Full Text] [Related]

  • 2. Can intermediate-energy sources lead to elevated bone doses for prostate and head & neck high-dose-rate brachytherapy?
    Famulari G, Alfieri J, Duclos M, Vuong T, Enger SA.
    Brachytherapy; 2020 Jan 01; 19(2):255-263. PubMed ID: 31964601
    [Abstract] [Full Text] [Related]

  • 3. MONTE CARLO-BASED INVESTIGATION OF MICRODOSIMETRIC DISTRIBUTION OF HIGH ENERGY BRACHYTHERAPY SOURCES.
    Chattaraj A, Selvam TP, Datta D.
    Radiat Prot Dosimetry; 2019 Dec 31; 187(1):115-128. PubMed ID: 31165891
    [Abstract] [Full Text] [Related]

  • 4. Approaches to calculating AAPM TG-43 brachytherapy dosimetry parameters for 137Cs, 125I, 192Ir, 103Pd, and 169Yb sources.
    Melhus CS, Rivard MJ.
    Med Phys; 2006 Jun 31; 33(6):1729-37. PubMed ID: 16872080
    [Abstract] [Full Text] [Related]

  • 5. Calculated microdosimetric characteristics of 125I and 103Pd brachytherapy seeds at different depths in water.
    Wuu CS, Chen J.
    Radiat Prot Dosimetry; 2006 Jun 31; 122(1-4):506-8. PubMed ID: 17189276
    [Abstract] [Full Text] [Related]

  • 6. Maximum RBE change in 192Ir, 125I, and 169Yb brachytherapy and the corresponding effect on treatment planning.
    Nusrat H, Karim-Picco S, Pang G, Paudel M, Sarfehnia A.
    Biomed Phys Eng Express; 2020 Jan 13; 6(1):015021. PubMed ID: 33438609
    [Abstract] [Full Text] [Related]

  • 7. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D, Weinberg V, Cunha JA, Hsu IC, Pouliot J.
    Brachytherapy; 2011 Jan 13; 10(6):461-5. PubMed ID: 21397569
    [Abstract] [Full Text] [Related]

  • 8. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F, Granero D, Perez-Calatayud J, Venselaar JL, Rivard MJ.
    Med Phys; 2010 Apr 13; 37(4):1629-37. PubMed ID: 20443484
    [Abstract] [Full Text] [Related]

  • 9. Gadolinium-153 as a brachytherapy isotope.
    Enger SA, Fisher DR, Flynn RT.
    Phys Med Biol; 2013 Feb 21; 58(4):957-64. PubMed ID: 23339848
    [Abstract] [Full Text] [Related]

  • 10. Microdosimetric evaluation of relative biological effectiveness for 103Pd, 125I, 241Am, and 192Ir brachytherapy sources.
    Wuu CS, Kliauga P, Zaider M, Amols HI.
    Int J Radiat Oncol Biol Phys; 1996 Oct 01; 36(3):689-97. PubMed ID: 8948355
    [Abstract] [Full Text] [Related]

  • 11. Direction modulated brachytherapy (DMBT) for treatment of cervical cancer: A planning study with 192 Ir, 60 Co, and 169 Yb HDR sources.
    Safigholi H, Han DY, Mashouf S, Soliman A, Meigooni AS, Owrangi A, Song WY.
    Med Phys; 2017 Dec 01; 44(12):6538-6547. PubMed ID: 28940520
    [Abstract] [Full Text] [Related]

  • 12. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT, Munro Iii JJ, Medich DC.
    J Appl Clin Med Phys; 2015 May 08; 16(3):5270. PubMed ID: 26103489
    [Abstract] [Full Text] [Related]

  • 13. Comparison of 192 Ir, 169 Yb, and 60 Co high-dose rate brachytherapy sources for skin cancer treatment.
    Safigholi H, Meigooni AS, Song WY.
    Med Phys; 2017 Sep 08; 44(9):4426-4436. PubMed ID: 28494095
    [Abstract] [Full Text] [Related]

  • 14. EGSnrc Monte Carlo calculated dosimetry parameters for 192Ir and 169Yb brachytherapy sources.
    Taylor RE, Rogers DW.
    Med Phys; 2008 Nov 08; 35(11):4933-44. PubMed ID: 19070227
    [Abstract] [Full Text] [Related]

  • 15. Microdosimetric study on influence of low energy photons on relative biological effectiveness under therapeutic conditions using 6 MV linac.
    Okamoto H, Kohno T, Kanai T, Kase Y, Matsumoto Y, Furusawa Y, Fujita Y, Saitoh H, Itami J.
    Med Phys; 2011 Aug 08; 38(8):4714-22. PubMed ID: 21928645
    [Abstract] [Full Text] [Related]

  • 16. Microdosimetry calculations for monoenergetic electrons using Geant4-DNA combined with a weighted track sampling algorithm.
    Famulari G, Pater P, Enger SA.
    Phys Med Biol; 2017 Jul 07; 62(13):5495-5508. PubMed ID: 28486214
    [Abstract] [Full Text] [Related]

  • 17. Monte Carlo characterization of a new Yb-169 high dose rate source for brachytherapy application.
    Cazeca MJ, Medich DC, Munro JJ.
    Med Phys; 2010 Mar 07; 37(3):1129-36. PubMed ID: 20384248
    [Abstract] [Full Text] [Related]

  • 18. Evaluation of high-energy brachytherapy source electronic disequilibrium and dose from emitted electrons.
    Ballester F, Granero D, Pérez-Calatayud J, Melhus CS, Rivard MJ.
    Med Phys; 2009 Sep 07; 36(9):4250-6. PubMed ID: 19810499
    [Abstract] [Full Text] [Related]

  • 19. Investigation the effect of a magnetic field on the dose distribution of I-125, Ir-192, Yb-169, and Co-60 brachytherapy sources by Monte Carlo simulation.
    Jafarzadeh N, Hejazi P, Tajik Mansoury MA, Khodabakhshi R, Riazi Z, Gholami S.
    Appl Radiat Isot; 2022 Sep 07; 187():110332. PubMed ID: 35717903
    [Abstract] [Full Text] [Related]

  • 20. Microdosimetric spread for cell-sized targets exposed to ⁶⁰Co, ¹⁹²Ir and ¹²⁵I sources.
    Villegas F, Tilly N, Ahnesjö A.
    Radiat Prot Dosimetry; 2015 Sep 07; 166(1-4):365-8. PubMed ID: 25911409
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.